Sunday 06 May
Immune cell crosstalk in atherosclerosis

Distant control of plaque formation

Filip K. Swirski, Boston, USA

Functional immune cell interactions and plaque development

Ziad Mallat, Cambridge, United Kingdom

Monday 07 May
Macrophages and foam-cells in the vessel wall

Senescent intimal foam cells are deleterious at all stages of atherosclerosis

Jan M. van Deursen, Rochester, USA

Role of TLR4 in lipid induced macrophage inflammation

Mark Febbraio, Darlinghurst, Australia

Sunday 06 May
Role of endothelial and SMC cells in atherogenesis

Transcriptional control of endothelial energy

Michael Potente, Bad Nauheim, Germany

Vascular smooth muscle cells in atherosclerosis

Gary K. Owens, Charlottesville, USA

Tuesday 08 May
Molecular-cellular mechanisms that mediate vascular disease

The role of efferocytosis in atherosclerosis

Nicholas J. Leeper, Boston, USA

Clonal hematopoiesis in atherosclerosis

Alan Tall, New York, USA


Monday 07 May
Cholesterol and cellular lipid metabolism

The role of bile acids in cholesterol homeostatis

Albert K. Groen, Groningen, The Netherlands

Lipid signaling pathways in physiology and disease

Peter Tontonoz, Los Angeles, USA

Sunday 06 May
Lipoprotein receptors - and regulation

PCSK9 biology beyond the liver

Giuseppe D. Norata, Milan, Italy

Lipoprotein metabolism in the brain

Joachim Herz, Dallas, USA

Monday 07 May
Integrative physiology and systems medicine to understand metabolism and cardiometabolic disease

Nonalcoholic liver hepatic steatosis: a systems biology approach

Adil Mardinoglu, Stockholm, Sweden

Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrix

Manuel Mayr, London, United Kingdom


Sunday 06 May
Novel targets for dyslipidemia and cardiovascular disease

Nanomedicine as novel atherosclerosis thearpy

Willem J.M. Mulder, New York, USA

Are we ready to test the Lp(a) hypothesis?

Sotirios Tsimikas, San Diego, USA

Monday 07 May
Novel technologies for cardiovascular research

Potential and caveats of lipidomics for cardiovascular disease

Edward A. Dennis, San Diego, USA

Cardiovascular gene therapy

Seppo Ylä-Herttuala, Kuopio, Finland

Tuesday 08 May
Healthy food and lifestyle to prevent and treat atherometabolic diseases

Lessons from the "Prevention with Mediterranean Diet" (Predimed) study

Emilio Ros, Barcelona, Spain

How to combat CVD at a population level?

Nick J. Wareham, Cambridge, United Kingdom

Generic risk, adherence to a healthy lifestyle, and cardiovascular disease

Anne Tybjaerg-Hansen, Copenhagen, Denmark